This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Desensitization to allergens
Z21_DESEN_ALLERGE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2583 |
4. Check minimum number of eventsNone |
2583 |
5. Include endpointsNone |
2583 |
6. Filter based on genotype QC (FinnGen only) |
2340 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- HYPOSENSIBILIZATIONTHRPY
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z51
Similar endpoints
↥List of similar endpoints to
Desensitization to allergens
based on the number of shared cases.
Similar with more cases:
- Other medical care
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2340 | 1596 | 744 |
| Unadjusted period prevalence (%) | 0.49 | 0.57 | 0.34 |
| Median age at first event (years) | 31.56 | 32.06 | 30.49 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2463
- Matched controls
- 24630
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R06AE07
ATC
cetirizine; oral
6.2
307.7
1939
9190
R06AX22
ATC
ebastine; oral
5.2
307.7
984
2780
C01CA24
ATC
epinephrine; parenteral
37.3
307.7
1544
1062
3023
Kela drug reimbursment
Allergen extract of birch pollen (adults)
125.3
307.7
317
29
R03DC03
ATC
montelukast; oral
6.0
307.7
1068
2767
R06AX27
ATC
desloratadine; oral
5.6
307.7
1651
6550
V01AA02
ATC
grass pollen; parenteral
128.6
307.7
353
32
J45.0
ICD-10 Finland
Predominantly allergic asthma
12.8
307.7
1130
1527
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
79.4
307.7
2036
1396
WQ000
NOMESCO Finland
Hyposensibilisation
436.1
307.7
777
26
V01AA05
ATC
tree pollen; parenteral
55.4
307.7
465
103
R97
ICPC
Allergic rhinitis
11.5
307.7
373
376
S01GX01
ATC
cromoglicic acid; ophthalmic
11.6
307.7
1697
3946
SPAT1267
SPAT
Desensitisation
234.3
307.7
214
10
R06AE09
ATC
levocetirizine; oral
5.2
307.7
956
2680
H02AB06
ATC
prednisolone; systemic
6.2
307.7
1784
7332
XQ800
NOMESCO Finland
Prick test
10.5
307.7
918
1318
Z51.6
ICD-10 Finland
Desensitization to allergens
+∞
307.7
2463
9
J30.3
ICD-10 Finland
Other allergic rhinitis
11.1
307.7
529
591
R03BA02
ATC
budesonide; inhalant
4.9
307.6
954
2791
R06AX13
ATC
loratadine; oral
4.9
305.7
946
2761
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.0
305.4
927
2664
R03AC02
ATC
salbutamol; inhalant
6.1
285.8
2060
11182
XG410
NOMESCO Finland
Flow-volume spirometry
10.7
267.8
308
324
J30.19
ICD-10 Finland
Pollen allergy UNS
6.3
266.2
520
1006
R01AD08
ATC
fluticasone; nasal
4.1
259.0
1282
5178
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
5.3
255.8
628
1492
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
8.6
251.1
347
462
S01GX02
ATC
levocabastine; ophthalmic
6.6
246.4
450
812
R01AD58
ATC
fluticasone, combinations; nasal
3.9
243.4
1319
5608
J45.9
ICD-10 Finland
Asthma, unspecified
4.1
226.3
841
2736
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
7.5
222.7
347
528
XG474
NOMESCO Finland
Exhalation nntrogen oxide
9.4
212.2
266
312
R06AX26
ATC
fexofenadine; oral
5.3
211.9
490
1094
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.2
208.6
711
2159
R01AD09
ATC
mometasone; nasal
3.7
199.5
1722
9477
A92
ICPC
Allergy/allergic reaction NOS
6.4
196.3
359
643
S01GX08
ATC
ketotifen; ophthalmic
5.8
186.5
376
738
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
13.8
178.2
169
131
R03BA05
ATC
fluticasone; inhalant
3.5
170.6
816
3066
R03AC03
ATC
terbutaline; inhalant
3.9
166.8
608
1907
L20.0
ICD-10 Finland
Besnier prurigo
3.9
165.1
603
1893
J45
ICD-10 Finland
Asthma
4.1
162.0
532
1548
R01AD05
ATC
budesonide; nasal
5.0
158.4
384
882
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
5.3
155.8
346
737
J30.1
ICD-10 Finland
Allergic rhinitis due to pollen
43.4
153.9
92
22
R01AD12
ATC
fluticasone furoate; nasal
3.0
153.7
1334
6979
T78.4
ICD-10 Finland
Allergy, unspecified
5.0
145.9
347
782
R01AC01
ATC
cromoglicic acid; nasal
5.4
138.8
298
614
R01AD01
ATC
beclometasone; nasal
3.4
129.6
584
2074
T63.4
ICD-10 Finland
Toxic effect: Venom of other arthropods
13.1
128.1
124
99
R96
ICPC
Asthma
3.9
118.1
400
1173
R03AK07
ATC
formoterol and budesonide; inhalant
2.8
114.7
799
3601
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
7.1
109.9
172
259
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.4
108.7
471
1618
R03BA01
ATC
beclometasone; inhalant
3.3
107.3
472
1636
R03BA08
ATC
ciclesonide; inhalant
3.7
105.3
372
1119
H02AB07
ATC
prednisone; oral
3.5
103.0
400
1280
R06AX12
ATC
terfenadine; oral
5.2
102.9
227
476
E0000UV, ,
ATC
2.4
101.7
1347
8130
R03AC13
ATC
formoterol; inhalant
5.6
94.5
188
359
S01GX09
ATC
olopatadine; ophthalmic
5.3
93.0
196
394
364
Kela drug reimbursment
Allergen extract of birch pollen and allergen extract of grass pollen
168.2
92.9
97
6
Z3231
NOMESCO Finland
Registered nurse
2.5
88.0
800
4020
D11AH01
ATC
tacrolimus; topical
8.2
84.7
115
147
R01AD11
ATC
triamcinolone; nasal
3.4
82.9
327
1050
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.2
81.4
233
600
R01BA52
ATC
pseudoephedrine, combinations; oral
2.4
81.3
765
3880
D07AB08
ATC
desonide; topical
3.0
81.3
422
1594
J45.8
ICD-10 Finland
Mixed asthma
5.8
81.2
153
277
L27.2
ICD-10 Finland
Dermatitis due to ingested food
6.4
80.4
138
228
R03BB04
ATC
tiotropium bromide; inhalant
4.3
79.4
219
548
H02AB04
ATC
methylprednisolone; systemic
3.0
79.3
413
1561
R03AK08
ATC
formoterol and beclometasone; inhalant
4.5
77.8
201
478
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
4.7
76.5
184
413
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.8
75.5
180
401
E000001, ,
ATC
2.4
75.1
704
3546
R01AC02
ATC
levocabastine; nasal
4.9
74.8
171
368
J30.0
ICD-10 Finland
Vasomotor rhinitis
5.5
70.5
140
266
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
7.4
69.3
102
143
R06AX18
ATC
acrivastine; oral
5.9
68.7
126
222
E000002, ,
ATC
2.6
67.6
453
1943
R03AC12
ATC
salmeterol; inhalant
5.1
64.3
138
281
R06AX11
ATC
astemizole; oral
4.3
63.1
171
421
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
3.5
61.7
229
703
D07AA02
ATC
hydrocortisone; topical
2.3
57.5
550
2755
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.5
54.3
411
1854
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.8
50.4
281
1089
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.0
49.9
233
819
D11AH02
ATC
pimecrolimus; topical
9.7
49.6
58
61
L20
ICD-10 Finland
Atopic dermatitis
3.2
48.3
207
692
D11AX14
ATC
[U] tacrolimus
10.4
46.7
52
51
S01GX05
ATC
lodoxamide; ophthalmic
7.3
46.7
69
97
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
7.0
46.3
71
104
D11AH05
ATC
dupilumab; topical
13.7
46.0
43
32
D07AC01
ATC
betamethasone; topical
1.9
45.7
882
5632
J31.0
ICD-10 Finland
Chronic rhinitis
2.5
45.6
313
1343
395
Kela drug reimbursment
Dupilumab
13.8
45.1
42
31
R06.2
ICD-10 Finland
Wheezing
3.2
43.6
183
604
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.6
41.3
142
413
D07AC13
ATC
mometasone; topical
1.9
41.1
710
4346
J01FA10
ATC
azithromycin; systemic
1.8
40.7
1707
13584
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
40.6
808
5168
L50.0
ICD-10 Finland
Allergic urticaria
3.6
40.2
137
396
XQ802
NOMESCO Finland
Epicutan test
3.2
40.1
166
543
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.2
39.9
405
2050
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
8.4
39.9
52
63
S01GX04
ATC
nedocromil; ophthalmic
5.0
39.3
85
174
E000007, ,
ATC
2.7
35.9
206
806
D02AX
ATC
Other emollients and protectives
3.3
35.9
138
431
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
35.9
755
4876
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.6
35.4
118
336
R03BC01
ATC
cromoglicic acid; inhalant
4.6
35.4
86
194
J45.1
ICD-10 Finland
Nonallergic asthma
2.6
35.3
217
879
R03DA04
ATC
theophylline; systemic, rectal
3.9
35.1
104
273
ZX112
NOMESCO Finland
Subcutaneous
5.2
34.7
72
142
J30.2
ICD-10 Finland
Other seasonal allergic rhinitis
11.0
34.7
37
34
WQ000, ,
SPAT
58.0
34.3
40
7
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.8
33.7
181
685
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.1
33.5
143
476
J46
ICD-10 Finland
Status asthmaticus
3.9
33.0
99
262
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
12.5
32.4
32
26
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
32.3
786
5259
D02AE01
ATC
carbamide; topical
2.7
32.1
182
708
R03AK11
ATC
formoterol and fluticasone; inhalant
4.0
29.7
84
213
DHB50
NOMESCO Finland
Turbinoplasty
3.5
29.7
106
316
J33.8
ICD-10 Finland
Other polyp of sinus
4.7
29.5
68
147
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
29.4
538
3303
501
Kela drug reimbursment
Cow's milk and / or soy protein allergy in young children
3.9
29.2
88
234
J01FA06
ATC
roxithromycin; oral
1.7
29.0
834
5800
N05BB01
ATC
hydroxyzine; systemic
2.4
28.3
197
845
R03BC03
ATC
nedocromil; inhalant
2.7
28.1
158
611
J30
ICD-10 Finland
Vasomotor and allergic rhinitis
3.4
27.6
102
311
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
3.6
27.5
94
272
W57
ICD-10 Finland
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
2.9
27.4
137
498
R01AD59
ATC
mometasone, combinations; nasal
2.1
27.4
285
1445
D11AX15
ATC
[U] pimecrolimus
9.3
27.4
33
36
J32.4
ICD-10 Finland
Chronic pansinusitis
4.7
26.9
63
138
S01GX06
ATC
emedastine; ophthalmic
5.0
26.3
56
113
E000006, ,
ATC
2.5
26.2
176
743
R06.0
ICD-10 Finland
Dyspnoea
1.7
26.1
525
3302
XQ899
NOMESCO Finland
Other assessment of skin
7.8
25.9
36
47
J01AA02
ATC
doxycycline; systemic
1.6
25.7
1617
13413
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
25.2
1702
14321
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
24.4
1410
11404
X27
ICD-10 Finland
Contact with other specified venomous animals
20.3
24.3
36
18
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
4.9
23.7
52
108
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
23.5
779
5547
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
23.4
563
3704
XG405
NOMESCO Finland
Education on PEF monitoring
4.8
22.9
51
107
R01AC07
ATC
nedocromil; nasal
8.6
22.8
29
34
T78.3
ICD-10 Finland
Angioneurotic oedema
4.9
22.7
50
104
J34.2
ICD-10 Finland
Deviated nasal septum
2.5
22.7
144
591
UDM02
NOMESCO Finland
Sinoscopy
3.7
22.6
72
199
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
22.0
783
5653
E000003, ,
ATC
2.5
21.6
136
556
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.4
21.2
78
237
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
3.2
20.9
82
260
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
20.4
458
2946
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.8
20.4
101
366
J01FA09
ATC
clarithromycin; systemic
1.5
20.2
758
5514
R03DC01
ATC
zafirlukast; oral
5.1
19.8
41
81
A02BC05
ATC
esomeprazole; systemic
1.5
19.7
784
5768
R01AC03
ATC
azelastine; nasal
8.2
19.6
26
32
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
4.5
19.2
47
107
R03CC02
ATC
salbutamol; systemic
1.8
19.1
343
2072
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.7
18.8
381
2381
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.6
18.6
492
3294
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
4.0
18.2
51
129
J02AC01
ATC
fluconazole; systemic
1.5
18.0
945
7329
D07CC01
ATC
betamethasone and antibiotics; topical
1.8
17.8
274
1581
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.9
17.6
38
78
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
17.1
17.4
27
16
R06AE08, ,
ATC
4.9
17.1
37
76
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
5.7
16.8
31
55
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.8
16.8
254
1457
M79.6
ICD-10 Finland
Pain in limb
1.4
16.7
992
7840
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
6.5
16.7
27
42
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
4.8
16.6
37
78
49300
ICD-8 Finland
Asthma, bronchiale
3.8
16.6
51
138
V01AA03
ATC
house dust mites; parenteral
171.1
16.5
17
*
A12
ICPC
ALLERGY/ALLERGIC REACTION
5.7
16.3
30
53
Z2221
NOMESCO Finland
Medical doctor
1.5
16.3
620
4488
X57
ICD-10 Finland
Unspecified privation
3.1
16.3
67
219
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
16.1
123
549
R02
ICPC
Shortness of breath/dyspnoea
1.8
16.0
273
1621
A02BC02
ATC
pantoprazole; systemic
1.4
16.0
1329
11129
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.9
16.0
214
1180
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
16.0
559
3973
SPAT1057
SPAT
Peak expiratory flow measurement
3.2
15.9
62
196
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
3.6
15.9
52
147
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.7
15.9
87
333
D07AD01
ATC
clobetasol; topical
1.7
15.7
324
2029
J01DB01
ATC
cefalexin; oral
1.5
15.7
1988
17992
Z01.7
ICD-10 Finland
Laboratory examination
1.6
15.4
400
2656
M25.5
ICD-10 Finland
Pain in joint
1.4
15.3
780
5967
R03BB01
ATC
ipratropium bromide; inhalant
3.9
15.3
45
118
X58
ICD-10 Finland
Exposure to other specified factors
1.6
15.0
411
2763
X48
ICD-10 Finland
Accidental poisoning by and exposure to pesticides
31.9
14.8
19
6
M01AE02
ATC
naproxen; oral, rectal
1.4
14.6
1413
12065
S87
ICPC
Dermatitis/atopic eczema
2.4
14.6
99
420
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.8
14.6
246
1456
J01AA04
ATC
lymecycline; systemic
1.6
14.4
397
2669
J37.0
ICD-10 Finland
Chronic laryngitis
2.7
14.2
75
282
-55
ICPC
Local injection/infiltration
6.7
14.0
22
33
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
13.8
432
2985
A02BC01
ATC
omeprazole; systemic
1.5
13.8
481
3402
W84
ICD-10 Finland
Unspecified threat to breathing
10.5
13.7
26
25
R05
ICD-10 Finland
Cough
1.5
13.6
485
3446
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
12.1
13.6
24
20
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
13.5
259
1590
XQ820
NOMESCO Finland
Exposure to medicinal substance
5.6
13.4
25
45
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
13.3
924
7422
DHB20
NOMESCO Finland
Polypectomy of internal nose
4.1
13.3
36
89
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
13.2
243
1473
J20
ICD-10 Finland
Acute bronchitis
1.7
13.2
244
1482
J05AB11
ATC
valaciclovir; oral
1.6
12.9
312
2031
L20.8
ICD-10 Finland
Other atopic dermatitis
3.2
12.9
49
153
Z71.8
ICD-10 Finland
Other specified counselling
1.4
12.7
890
7145
M03BX02
ATC
tizanidine; oral
1.4
12.7
1361
11693
J02AC02
ATC
itraconazole; systemic
1.6
12.6
327
2163
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
4.4
12.6
31
71
R4110
NOMESCO Finland
Physiotherapy
1.5
12.5
508
3698
D19
ICPC
Teeth/gum symptom/complaint
1.4
12.5
841
6702
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
12.5
689
5312
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
12.3
392
2718
H10
ICD-10 Finland
Conjunctivitis
1.7
12.2
240
1480
S01BA01
ATC
dexamethasone; ophthalmic
2.7
12.1
65
247
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
12.1
444
3169
S01XA18
ATC
ciclosporin; ophthalmic
4.9
11.7
25
51
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
1.5
11.6
355
2435
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
3.6
11.6
37
103
Z01.2
ICD-10 Finland
Dental examination
1.3
11.5
1267
10859
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.6
11.5
317
2125
S01AD03
ATC
aciclovir; ophthalmic
2.5
11.5
72
295
R01BA01
ATC
phenylpropanolamine; oral
2.1
11.4
102
487
M02AA07
ATC
piroxicam; topical
1.4
11.3
500
3693
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
8.9
11.2
23
26
H10.4
ICD-10 Finland
Chronic conjunctivitis
3.7
11.2
35
96
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
11.2
454
3300
GD1AA, ,
SPAT
1.5
11.1
455
3312
J01DA06
ATC
[U] cefuroxime
1.6
10.9
291
1937
SPAT1324
SPAT
Screening procedure
0.6
10.9
212
3309
SPAT1058
SPAT
PEF monitoring instruction
1.9
10.8
147
814
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
4.6
10.7
25
55
Z3226
NOMESCO Finland
Physiotherapist
1.5
10.7
338
2335
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.1
10.6
105
523
J05AB01
ATC
aciclovir; systemic
1.4
10.6
450
3298
D07AC14
ATC
methylprednisolone aceponate; topical
2.1
10.5
99
483
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.7
10.4
209
1297
A02BC04
ATC
rabeprazole; oral
1.7
10.4
183
1096
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
10.4
737
5890
ZXC60
NOMESCO Finland
Application of heat
3.2
10.3
39
122
R49.01
ICD-10 Finland
Functional dysphonia
2.4
10.2
66
275
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
10.2
931
7720
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
10.1
112
580
DPA30
NOMESCO Finland
Sphenotomy
4.2
10.1
26
62
D07BC01
ATC
betamethasone and antiseptics; topical
1.7
10.1
203
1261
L50.9
ICD-10 Finland
Urticaria, unspecified
1.9
9.9
121
648
M01AH05
ATC
etoricoxib; oral
1.3
9.9
1292
11245
J01DC02
ATC
cefuroxime; systemic
1.9
9.7
130
718
N02AX02
ATC
tramadol; systemic, rectal
1.3
9.7
708
5673
XQ830
NOMESCO Finland
Exposure to foodstuff
10.1
9.5
18
18
R51.80
ICD-10 Finland
Headache
1.4
9.5
438
3252
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
9.5
193
1202
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.4
9.4
629
4965
R29
ICPC
Respiratory symptom/complaint other
1.7
9.4
164
980
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
5.2
9.4
19
37
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
9.3
404
2966
ZX101
NOMESCO Finland
Sublingual
24.1
8.9
12
5
M79.1
ICD-10 Finland
Myalgia
1.4
8.8
377
2758
D09AB01
ATC
zinc bandage without supplements; topical
3.1
8.8
36
118
E0001A1, ,
ATC
2.1
8.8
77
366
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
8.8
248
1670
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
3.3
8.8
32
98
F29
ICPC
Eye symptom/complaint other
1.5
8.7
244
1639
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.6
8.7
200
1285
J04.0
ICD-10 Finland
Acute laryngitis
1.8
8.6
139
813
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
1.9
8.6
111
607
R74
ICPC
Upper respiratory infection acute
1.3
8.6
1074
9231
WX002
NOMESCO Finland
Sedation and analgesia
1.5
8.6
282
1962
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.4
8.5
434
3272
J01MA06
ATC
norfloxacin; oral
1.6
8.5
198
1274
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
3.2
8.5
33
105
R49.08
ICD-10 Finland
Other specified dysphonia
2.6
8.5
48
188
R83
ICPC
Respiratory infection other
1.3
8.4
835
6962
WQ034, ,
NOMESCO Finland
+∞
8.3
8
*
WZC30
NOMESCO Finland
Teaching
1.5
8.3
268
1857
XQ801
NOMESCO Finland
Intracutantest
4.1
8.3
22
54
M03AX01
ATC
botulinum toxin; parenteral
2.4
8.2
56
240
J01FA15
ATC
telithromycin; oral
1.6
8.2
179
1135
A07AA02
ATC
nystatin; oral
2.0
8.2
83
418
D06AX01
ATC
fusidic acid; topical
1.6
8.2
212
1401
H10.5
ICD-10 Finland
Blepharoconjunctivitis
2.4
8.1
53
223
J01FA01
ATC
erythromycin; systemic
1.4
8.1
361
2660
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.6
8.1
200
1307
D10AX03
ATC
azelaic acid; topical
1.5
8.1
262
1817
TUPEI, ,
NOMESCO Finland
1.8
8.1
110
612
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.6
8.0
186
1198
H01.0
ICD-10 Finland
Blepharitis
1.6
8.0
187
1206
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
3.5
8.0
26
74
S01AA01
ATC
chloramphenicol; ophthalmic
1.9
8.0
105
578
E000008, ,
ATC
7.2
8.0
18
25
A06AC51
ATC
ispaghula, combinations; oral
2.0
7.9
80
402
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
7.9
479
3716
D07CB01
ATC
triamcinolone and antibiotics; topical
2.8
7.9
37
132
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
8.5
7.8
16
19
S12
ICPC
Insect bite/sting
1.7
7.8
131
776
J01AA07
ATC
tetracycline; systemic
1.4
7.8
370
2756
A98
ICPC
Health maint/preventive medicine
3.0
7.7
2438
23893
J01CA04
ATC
amoxicillin; systemic
1.4
7.6
2084
19678
E000004, ,
ATC
2.3
7.6
53
230
C09CA06
ATC
candesartan; oral
1.4
7.6
387
2917
J01DA01
ATC
[U] cefalexin
1.3
7.6
1275
11303
ZXD20
NOMESCO Finland
Day surgery
1.5
7.5
236
1624
M01AB01
ATC
indometacin; systemic, rectal
2.2
7.5
58
263
D06BB03
ATC
aciclovir; topical
1.9
7.5
84
439
4222
FHL
Endonasal etmoidectomy
7.1
7.5
17
24
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
7.5
811
6813
D10AF01
ATC
clindamycin; topical
1.7
7.4
121
710
H01.1
ICD-10 Finland
Noninfectious dermatoses of eyelid
4.4
7.4
18
41
D07XB05
ATC
dexamethasone; topical
2.3
7.4
54
239
R53
ICD-10 Finland
Malaise and fatigue
1.3
7.4
571
4585
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.5
7.3
221
1509
L15
ICPC
Knee symptom/complaint
1.3
7.3
494
3888
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.5
7.2
218
1488
A04
ICPC
Weakness/tiredness general
1.4
7.2
386
2930
-2, ,
ICD-10 Finland
1.9
7.2
90
488
A02BA02
ATC
ranitidine; systemic
1.5
7.2
223
1533
N95.1
ICD-10 Finland
Menopausal and female climacteric states
1.4
7.2
284
2047
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
7.2
538
4300
K07.61
ICD-10 Finland
Cracking jaw joint
2.0
7.1
74
377
D07XC01
ATC
betamethasone; topical
1.6
7.1
186
1233
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
4.1
7.1
19
47
J32
ICD-10 Finland
Chronic sinusitis
3.0
7.0
29
96
R06AX25
ATC
mizolastine; oral
7.0
7.0
16
23
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.4
7.0
279
2014
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.0
7.0
30
102
OAB43, ,
SPAT
1.3
7.0
1144
10073
M01AG02
ATC
tolfenamic acid; oral, rectal
1.4
7.0
309
2273
L01
ICPC
Neck symptom/complaint
1.4
6.9
390
2984
L13
ICPC
Hip symptom/complaint
1.4
6.9
265
1899
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
4.0
6.9
19
48
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.9
712
5934
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
6.9
647
5328
R05
ICPC
Cough
1.3
6.9
569
4607
KAY40, ,
NOMESCO Finland
1.6
6.9
142
890
ZXA10
NOMESCO Finland
Bilateral
1.4
6.8
281
2041
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
2.9
6.8
31
109
EB1SA, ,
SPAT
1.6
6.8
137
853
OAB95, ,
SPAT
1.4
6.8
290
2120
T63.8
ICD-10 Finland
Toxic effect: Toxic effect of contact with other venomous animals
40.2
6.8
8
*
L29
ICPC
Musculoskeletal sympt/complt other
1.6
6.7
168
1103
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
2.1
6.6
58
277
XX9CW
NOMESCO Finland
Submitting image material and/or investigation material to patient
3.6
6.6
21
59
R01AX03
ATC
ipratropium bromide; nasal
2.8
6.6
31
111
D06BX01
ATC
metronidazole; topical
1.5
6.6
201
1377
A02BC03
ATC
lansoprazole; oral
1.4
6.5
382
2940
A03FA02
ATC
cisapride; oral, rectal
1.8
6.5
95
541
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.6
6.5
142
902
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
6.5
375
2882
ZYC02, ,
SPAT
1.6
6.4
165
1088
V01AA07
ATC
insects; oral
70.0
6.4
7
*
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
6.4
920
7958
A69.2
ICD-10 Finland
Lyme disease
1.7
6.4
105
620
J01MA02
ATC
ciprofloxacin; systemic
1.3
6.3
590
4848
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.3
6.2
469
3746
DFF00
NOMESCO Finland
Pure tone audiometry
1.6
6.2
129
811
N02CC03
ATC
zolmitriptan; nasal, oral
1.6
6.2
143
922
WZB00, ,
SPAT
1.4
6.1
351
2691
R21
ICPC
Throat symptom/complaint
1.3
6.1
735
6221
R42
ICD-10 Finland
Dizziness and giddiness
1.4
6.1
347
2660
K05.31
ICD-10 Finland
Periodontitis pronounced
0.5
6.1
48
973
344
Kela drug reimbursment
Omalizumab
6.7
6.0
14
21
50708
ICD-8 Finland
Hay fever, Alia definita
10.0
6.0
11
11
TQW80
NOMESCO Finland
Local dermatologic skincare
2.3
6.0
45
202
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
6.0
579
4769
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
577
817
8.92
307.65
1.2
1.1
2.23
2.04
u/ml
0.18
434
428
609
933
8.34
307.65
1.2
1.2
2.87
2.88
u/ml
0.01
415
502
544
807
8.37
307.65
1.2
1.1
1.61
1.06
u/ml
1.02
407
364
634
831
9.93
307.65
1.2
1.1
9.79
6.06
u/ml
3.97
509
478
451
704
7.62
285.30
1.1
1.1
5.39
4.35
u/ml
0.54
324
369
422
660
7.51
265.75
1.1
1.1
6.68
5.59
u/ml
0.45
298
311
706
1901
4.80
246.39
1.6
1.3
567.79
246.13
u/ml
2.57
687
1776
387
611
7.33
240.74
1.1
1.1
0.55
0.35
u/ml
0.42
211
193
155
141
11.66
147.62
1.1
1.0
19.88
15.06
u/ml
0.84
107
91
123
94
13.72
130.41
1.3
1.1
9.93
10.87
u/ml
0.05
89
65
430
1313
3.76
119.83
1.6
1.4
—
—
—
0
0
153
184
8.80
118.71
1.5
1.5
5.73
7.57
ug/l
0.79
142
163
82
51
16.60
97.07
1.1
1.1
5.49
3.36
u/ml
0.20
60
44
55
11
51.12
95.29
1.1
1.4
2.65
1.37
u/ml
0.31
55
11
81
53
15.77
93.39
1.1
1.1
3.80
0.98
u/ml
0.82
61
42
78
52
15.46
89.02
1.0
1.0
0.40
0.07
u/ml
1.41
50
31
72
56
13.21
75.28
1.1
1.1
2.63
7.98
u/ml
0.31
36
26
65
48
13.88
70.01
1.0
1.0
1.84
4.15
u/ml
0.38
54
28
65
58
11.48
62.33
1.1
1.1
0.95
0.60
u/ml
0.15
37
27
118
215
5.71
62.10
1.2
1.3
8.03
2.34
u/ml
2.33
87
111
55
40
14.04
59.70
1.1
1.1
0.16
0.21
u/ml
0.10
55
40
60
53
11.58
57.89
1.1
1.0
0.27
0.65
u/ml
0.31
37
29
77
103
7.68
54.44
1.1
1.0
20.52
8.69
u/ml
1.80
35
20
1532
11280
1.95
53.63
5.4
7.2
0.22
0.18
e9/l
9.62
1348
10088
1413
10304
1.87
48.93
5.3
6.8
54.54
55.85
%
4.84
1361
9950
1422
10466
1.85
46.99
5.3
6.9
30.62
30.12
%
1.19
1368
10057
1504
11268
1.86
46.89
5.2
6.9
1.95
2.00
e9/l
1.44
1322
10167
106
240
4.57
43.42
1.1
1.1
1.14
1.91
u/ml
0.25
62
62
108
254
4.40
42.17
1.3
1.1
23.93
0.94
u/ml
0.76
57
71
1532
12029
1.72
35.81
6.7
9.6
3.64
3.96
e9/l
9.45
1313
10545
315
1830
1.83
20.07
3.6
3.4
31.87
31.33
%
0.43
234
1392
928
7106
1.49
19.13
1.9
1.8
99.45
98.64
pmol/l
0.21
512
3993
1708
14830
1.49
18.03
3.9
4.0
7.92
8.59
mm/h
2.14
1625
14085
756
5751
1.45
15.30
1.6
1.5
2.06
2.12
g/l
0.56
481
3870
62
210
3.00
14.19
2.7
2.0
4.30
2.16
u/ml
0.75
37
69
1158
9629
1.38
13.65
7.4
10.0
0.00
0.00
e9/l
0.82
885
7871
2048
18845
1.51
13.04
4.4
3.8
—
—
—
0
0
2255
21277
1.71
12.24
11.4
11.7
18.46
20.51
mg/l
2.62
1768
16870
520
3827
1.45
12.09
2.7
2.8
108.40
104.27
ug/g
0.09
401
3089
1424
12395
1.35
11.81
3.5
3.3
75.50
78.02
ug/l
0.24
1364
11853
1109
9298
1.35
11.77
2.5
2.6
75.25
71.75
nmol/l
4.12
1039
8804
831
6684
1.37
11.45
1.5
1.4
0.93
1.59
u/ml
3.04
228
1914
2106
19660
1.49
10.80
5.5
5.2
1.70
1.75
mu/l
1.52
2012
18832
2074
19303
1.47
10.80
9.4
9.9
95.77
96.20
ml/min/173m2
0.49
1833
17188
163
962
1.74
9.75
1.4
1.3
—
—
—
0
0
242
1588
1.58
9.60
2.5
2.4
16.74
18.55
au/ml
0.23
31
228
229
1486
1.60
9.53
1.3
1.3
46.63
36.84
au/ml
0.28
16
83
1875
17258
1.36
9.44
4.6
4.4
14.28
14.37
pmol/l
0.93
1757
16207
141
807
1.79
9.38
1.2
1.2
3.90
4.44
0.48
23
133
177
1086
1.68
9.20
1.8
1.7
—
—
—
0
0
28
86
3.28
7.66
1.3
1.2
94.54
91.41
%
0.22
28
86
125
753
1.70
7.01
1.6
2.0
0.21
0.23
g/l
1.03
125
714
128
780
1.68
6.89
1.6
2.0
1.15
1.18
g/l
0.85
128
742
53
244
2.20
6.64
1.8
1.5
0.61
0.52
e9/l
1.10
53
244
174
1155
1.54
6.60
1.4
1.8
3.66
4.75
mg/l
0.78
120
799
2291
22107
1.52
6.51
11.8
12.9
70.23
70.01
umol/l
0.22
2266
21871
375
2886
1.35
6.40
1.5
1.5
3.54
3.43
mmol/l
1.00
250
1893
45
197
2.31
6.36
1.5
1.3
—
—
—
0
0
147
958
1.57
6.06
1.7
1.7
5.87
10.67
u/ml
1.84
42
278
877
7583
1.24
6.01
1.8
1.8
—
—
—
0
0
2417
23695
2.07
5.86
17.2
17.7
263.63
262.59
e9/l
0.37
2380
23310
37
156
2.39
5.72
1.1
1.2
—
34.38
—
0
8
461
3713
1.30
5.68
1.9
1.7
3.48
3.48
ratio
0.01
337
2687
2417
23709
2.04
5.62
17.4
18.0
41.02
41.39
%
0.61
2411
23538
252
1857
1.40
5.62
2.7
2.3
12.69
12.37
nmol/l
0.24
230
1728
2417
23711
2.04
5.59
17.1
17.7
4.60
4.60
e12/l
0.27
2378
23303
575
4773
1.27
5.56
3.4
4.2
96.99
94.87
%
1.55
561
4668
522
4291
1.27
5.46
1.4
1.3
18.19
22.56
iu/ml
0.77
126
1174
2417
23719
2.02
5.45
17.3
17.8
137.57
137.11
g/l
1.09
2411
23554
40
179
2.26
5.42
1.1
1.2
—
75.54
—
0
13
2417
23722
2.01
5.40
17.2
17.7
6.49
6.72
e9/l
5.90
2376
23295
1727
16132
1.24
5.35
3.2
3.2
31.19
35.98
u/l
2.82
1667
15600
2415
23707
1.96
5.21
17.1
17.6
89.75
89.60
fl
1.05
2409
23546
95
580
1.66
5.15
1.2
1.1
21.76
15.65
au/ml
0.29
29
166
479
3932
1.27
5.04
1.3
1.3
7.85
9.04
u/ml
0.21
171
1684
1999
19046
1.26
4.83
12.6
14.3
13.14
13.24
%
4.45
1980
18810
77
455
1.71
4.74
1.2
1.1
2.92
2.80
0.03
16
82
49
252
1.96
4.69
1.2
1.1
5.55
7.26
iu/ml
0.27
12
69
71
1176
0.59
4.62
1.5
1.6
56.84
59.50
ug/l
0.24
71
1176
565
4777
1.24
4.55
2.0
2.0
0.64
0.90
mg/l
4.67
409
3499
25
98
2.57
4.55
1.1
1.3
107.88
106.51
%
0.10
25
85
1958
18647
1.24
4.53
3.7
3.7
5.48
5.62
mmol/l
7.20
1839
17662
6
235
0.25
4.19
19.8
22.7
1091.83
1404.54
nmol/l
—
6
229
2092
20122
1.26
4.13
10.5
11.7
3.88
3.91
mmol/l
5.10
2033
19637
2086
20073
1.26
4.00
10.3
11.6
139.64
139.58
mmol/l
0.71
2035
19649
232
1789
1.33
3.91
1.1
1.1
—
—
—
0
0
232
1789
1.33
3.91
2.3
3.0
10.42
10.39
g/l
0.05
211
1678
511
4338
1.22
3.91
1.7
1.5
19.65
19.83
nmol/l
0.13
449
3891
39
199
1.98
3.87
1.9
3.2
215.16
209.30
e6/l
0.07
32
160
2089
20126
1.25
3.83
4.3
4.2
2.83
2.84
mmol/l
0.23
1994
19327
38
193
1.98
3.83
1.8
3.2
503.16
533.08
e6/l
0.22
31
149
14
381
0.36
3.80
2.1
3.8
1.06
1.44
mmol/l
1.78
14
375
587
5067
1.21
3.79
2.3
2.3
2.38
2.58
mg/l
1.93
496
4450
710
6238
1.19
3.78
2.5
2.3
—
—
—
0
0
184
1378
1.36
3.77
1.7
1.9
1.23
1.27
g/l
0.21
166
1316
57
332
1.73
3.76
1.2
1.2
—
—
—
0
0
98
1436
0.67
3.74
1.5
1.6
—
—
—
0
0
2274
22161
1.34
3.67
9.2
9.7
26.50
26.70
u/l
0.20
2229
21701
1886
18013
1.20
3.60
4.1
4.5
35.87
36.98
mmol/mol
11.04
1816
17343
761
6761
1.18
3.53
2.6
2.4
—
—
—
0
0
2077
20037
1.23
3.51
4.0
4.0
4.72
4.72
mmol/l
0.09
1996
19316
281
2259
1.28
3.49
2.3
2.1
354.72
377.48
nmol/l
1.42
262
2104
81
1214
0.66
3.48
2.3
3.4
1.23
1.23
mmol/l
0.02
69
1039
2070
19968
1.23
3.47
4.0
3.9
1.47
1.45
mmol/l
0.90
1974
19169
505
4333
1.21
3.45
2.1
2.5
315.15
318.52
umol/l
0.40
463
3996
98
670
1.48
3.37
1.2
1.3
1.36
3.00
u/ml
—
5
63
26
121
2.16
3.32
1.3
1.1
—
—
—
0
0
355
2950
1.24
3.32
2.1
2.5
15.86
14.91
umol/l
1.56
345
2774
17
65
2.63
3.30
1.1
1.2
—
—
—
0
0
92
625
1.49
3.28
1.1
1.2
—
—
—
0
0
97
668
1.47
3.23
1.2
1.3
2.16
13.96
u/ml
—
9
102
196
1529
1.31
3.09
2.6
2.4
0.61
0.65
ug/l
0.31
79
690
112
801
1.42
3.07
1.5
1.6
—
—
—
0
0
90
618
1.47
3.06
1.1
1.2
—
—
—
0
0
1947
18740
1.19
2.98
3.4
3.4
1.21
1.24
mmol/l
0.77
1853
17935
12
37
3.25
2.93
1.2
1.3
1.74
1.53
iu/ml
—
6
18
28
142
1.98
2.90
1.8
1.6
23.00
21.92
mg/l
0.04
11
65
443
5110
0.84
2.88
2.3
3.3
1.02
1.64
kg/l
0.80
277
3263
95
1328
0.70
2.87
2.0
1.8
—
—
—
0
0
85
586
1.47
2.86
1.5
1.3
18.47
19.28
u/l
0.09
61
496
784
8632
0.87
2.82
2.6
3.1
0.03
0.02
estimate
0.22
155
1985
292
2427
1.23
2.74
2.2
2.6
26.16
24.43
%
1.26
277
2269
547
4818
1.17
2.74
2.2
2.2
—
—
—
0
0
232
1881
1.26
2.72
1.9
2.6
36.36
64.40
u/l
0.54
198
1580
13
48
2.72
2.71
1.2
1.1
—
—
—
0
0
274
2266
1.24
2.70
1.2
1.2
140.60
150.28
u/ml
0.13
97
869
1401
13216
1.14
2.62
4.0
3.9
3089.44
1400.32
e6/l
0.37
16
149
117
1554
0.74
2.60
2.9
2.7
—
—
—
0
0
84
590
1.44
2.59
1.3
1.3
—
—
—
0
0
9
25
3.61
2.57
1.0
1.2
19.51
34.31
mg/l
—
9
19
522
5886
0.86
2.55
2.9
3.5
0.01
0.00
estimate
0.29
187
2234
320
2705
1.21
2.55
2.1
2.4
2.46
2.46
g/l
0.02
305
2515
71
486
1.47
2.51
1.1
1.1
4.97
2.31
eliau/ml
1.29
36
248
868
7958
1.14
2.48
1.7
1.8
1.31
1.39
mmol/l
2.09
762
7133
87
621
1.42
2.47
2.4
1.9
—
—
—
0
0
124
939
1.34
2.46
2.4
2.4
68.76
67.82
g/l
0.87
118
894
10
32
3.13
2.43
1.2
1.3
0.36
0.32
iu/ml
—
5
15
46
288
1.61
2.43
1.1
1.1
14.08
17.38
u/ml
0.41
20
123
28
152
1.85
2.42
1.3
1.4
660.68
417.54
mu/l
0.68
28
146
39
234
1.68
2.42
1.3
1.4
—
—
—
0
0
76
533
1.44
2.39
1.2
1.3
—
8.06
—
0
7
27
146
1.86
2.37
1.2
3.2
403.37
718.33
u/ml
2.77
27
146
39
236
1.66
2.35
1.3
1.4
—
—
—
0
0
40
244
1.65
2.34
1.4
1.4
—
—
—
0
0
40
244
1.65
2.34
1.4
1.4
—
—
—
0
0
49
315
1.57
2.33
1.1
1.1
1.37
1.45
g/l
1.17
42
290
39
237
1.66
2.32
1.3
1.4
—
—
—
0
0
269
2258
1.21
2.32
1.4
1.5
19.97
20.56
iu/l
0.11
228
1888
334
2865
1.19
2.29
2.7
2.9
4.37
3.44
e6/l
0.51
134
1302
40
246
1.64
2.28
1.4
1.4
—
—
—
0
0
111
1452
0.75
2.26
8.8
9.7
0.29
0.61
mmol/l
0.60
96
1182
9
29
3.11
2.22
2.2
2.4
44.23
43.94
g/l
—
9
29
28
157
1.79
2.21
1.3
1.4
74.36
74.23
%
0.02
28
151
93
687
1.37
2.20
3.6
5.1
24.55
24.53
mmol/l
0.03
86
659
18
87
2.08
2.17
1.1
1.0
22.24
37.86
iu/ml
0.84
18
87
790
7255
1.13
2.14
5.2
6.6
1.22
1.22
mmol/l
1.08
733
6808
9
30
3.01
2.14
1.6
1.8
2.59
3.87
mg/l
—
9
22
9
30
3.01
2.14
1.6
1.8
1.42
1.17
mg/l
—
9
25
9
30
3.01
2.14
1.6
1.8
1.97
1.96
mg/l
—
9
23
9
30
3.01
2.14
1.6
1.8
1.53
2.03
mg/l
—
9
23
9
30
3.01
2.14
1.6
1.8
0.60
0.53
mg/l
—
9
22
52
763
0.67
2.12
1.8
2.5
1.02
1.02
ratio
0.53
42
673
23
123
1.88
2.11
2.0
1.9
—
—
—
0
0
13
56
2.33
2.04
1.2
1.1
—
—
—
0
0
9
32
2.82
2.00
1.6
1.8
0.92
0.67
mg/l
—
9
24
13
57
2.29
1.97
1.0
1.2
—
—
—
0
0
1502
14363
1.12
1.96
6.7
7.3
72.42
75.95
u/l
2.26
1422
13744
535
5913
0.88
1.92
2.4
2.7
57.47
58.12
u/l
0.07
496
5546
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
120
1.84
1.92
1.2
1.1
—
—
—
0
0
7
22
3.19
1.88
1.1
1.1
—
—
—
0
0
7
22
3.19
1.88
1.4
1.2
—
—
—
0
0
7
22
3.19
1.88
1.4
1.2
—
—
—
0
0
214
1799
1.21
1.85
1.8
1.7
353.95
300.79
mu/l
1.01
195
1624
247
2109
1.19
1.81
1.6
1.6
915.19
1152.85
nmol/l
4.53
176
1660
326
2851
1.17
1.80
2.7
2.4
2.40
2.41
mmol/l
0.88
286
2543
34
215
1.59
1.79
1.1
1.1
—
—
—
0
0
233
1983
1.19
1.78
2.8
3.1
18.49
21.49
%
1.59
54
609
55
388
1.43
1.75
1.1
1.2
—
—
—
0
0
16
296
0.54
1.73
1.8
2.9
1.39
1.40
mmol/l
0.02
16
283
11
230
0.48
1.72
2.0
3.0
5.77
7.02
mmol/l
3.00
11
220
633
5807
1.12
1.71
3.1
3.1
2.34
2.35
mmol/l
1.61
566
5419
133
1635
0.80
1.70
7.3
5.7
5.93
5.83
kpa
0.55
128
1587
46
316
1.46
1.69
1.2
1.3
—
—
—
0
0
46
316
1.46
1.69
1.2
1.3
—
—
—
0
0
22
126
1.75
1.68
1.0
1.1
—
—
—
0
0
14
69
2.03
1.64
2.7
3.4
2.49
1.90
ratio
0.69
14
62
77
582
1.33
1.64
1.2
1.2
62.27
35.21
u/ml
—
7
49
36
237
1.53
1.62
2.4
2.9
1.57
1.88
ratio
0.23
19
123
40
270
1.49
1.61
2.6
3.2
25.63
37.67
mg/l
0.82
35
230
40
270
1.49
1.61
2.6
3.2
33.60
58.04
mg/l
0.57
35
232
14
70
2.01
1.59
1.3
1.3
—
71.25
—
0
8
14
70
2.01
1.59
1.3
1.4
—
1560.00
—
0
5
130
1585
0.81
1.56
7.4
5.8
1.49
1.52
mmol/l
0.04
116
1354
74
562
1.33
1.54
2.5
1.8
—
—
—
0
0
24
145
1.66
1.54
2.3
1.9
0.11
0.57
mmol/l
0.46
24
139
160
1336
1.21
1.53
1.5
1.5
7.34
8.66
u/l
1.09
123
1066
876
8221
1.10
1.52
5.5
6.9
1.22
1.21
mmol/l
1.11
781
7188
28
177
1.59
1.51
1.0
1.2
118.07
114.74
pmol/l
0.16
28
177
308
2723
1.15
1.49
2.8
4.5
0.85
0.82
mmol/l
2.22
293
2597
40
275
1.46
1.49
1.3
1.4
5.26
6.14
umol/l
0.96
33
250
56
410
1.37
1.48
1.1
1.3
2.74
4.43
u/ml
1.21
31
182
32
210
1.53
1.48
1.3
1.1
—
—
—
0
0
146
1213
1.22
1.47
1.3
1.4
—
—
—
0
0
292
2579
1.15
1.44
4.1
3.5
1.31
1.59
ug/l
0.98
268
2371
101
810
1.26
1.42
1.1
1.3
3.23
3.73
ug/l
0.46
92
765
124
1020
1.23
1.39
1.6
2.1
16.93
7.66
iu/ml
0.52
15
257
99
798
1.25
1.34
1.1
1.1
3.77
5.34
eliau/ml
0.36
23
129
45
616
0.73
1.34
1.8
1.9
—
—
—
0
0
341
3062
1.13
1.33
2.7
2.7
0.76
1.13
e6/l
0.96
139
1500
31
451
0.68
1.31
1.3
1.6
—
—
—
0
0
6
24
2.50
1.30
1.3
1.1
—
—
—
0
0
30
201
1.50
1.29
1.3
1.1
—
—
—
0
0
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
31
210
1.48
1.27
1.2
1.1
—
—
—
0
0
27
179
1.51
1.23
1.2
1.3
186.43
176.44
pmol/l
0.15
27
179
19
116
1.64
1.21
4.4
3.6
—
—
—
0
0
2003
19637
1.11
1.20
12.9
14.3
333.85
333.75
g/l
0.19
1990
19514
30
206
1.46
1.17
1.2
1.1
—
—
—
0
0
71
561
1.27
1.17
1.6
1.6
320.87
367.98
mu/l
1.02
52
455
17
102
1.67
1.16
1.8
1.8
—
—
—
0
0
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
31
217
1.43
1.11
1.2
1.1
—
—
—
0
0
10
51
1.96
1.11
1.1
1.3
—
—
—
0
0
29
409
0.71
1.08
1.3
1.3
—
—
—
0
0
27
186
1.46
1.06
1.5
2.9
—
—
—
0
0
253
2267
1.13
1.05
2.7
3.1
5.68
6.54
umol/l
0.45
222
1933
16
98
1.64
1.03
1.3
1.1
89.14
92.58
%
—
7
52
7
34
2.06
1.03
1.9
1.4
—
—
—
0
0
130
1119
1.17
0.97
3.9
4.7
5.11
5.15
kpa
0.27
122
1079
16
100
1.60
0.96
1.0
1.1
98.29
92.13
%
—
7
53
18
116
1.56
0.96
1.1
1.1
107.16
205.86
iu/ml
2.82
18
116
13
77
1.69
0.95
1.0
1.0
—
—
—
0
0
9
51
1.77
0.94
1.2
1.1
—
—
—
0
0
6
27
2.23
0.93
1.7
1.6
—
—
—
0
0
6
120
0.50
0.93
1.5
1.7
—
—
—
0
0
54
427
1.27
0.93
1.1
1.1
—
—
—
0
0
115
987
1.17
0.90
3.8
4.8
0.79
1.36
mmol/l
1.17
78
703
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
16
102
1.57
0.90
1.2
1.1
121.50
107.85
%
0.89
16
97
115
1334
0.86
0.89
7.6
10.2
6.97
6.96
mmol/l
0.00
108
1296
276
2514
1.11
0.89
1.8
1.8
—
—
—
0
0
408
3789
1.09
0.89
1.5
1.8
1.33
1.38
%
1.35
367
3426
191
1704
1.13
0.88
1.5
1.5
57.18
60.11
ug/l
0.49
173
1431
10
56
1.79
0.87
1.1
1.1
—
—
—
0
0
7
131
0.53
0.87
2.7
3.3
12.71
42.87
u/ml
—
7
131
772
7360
1.07
0.86
4.3
5.1
37.98
37.47
g/l
2.05
721
6960
107
1239
0.86
0.83
1.4
1.9
—
—
—
0
0
6
113
0.53
0.83
1.5
1.1
—
—
—
0
0
74
617
1.21
0.82
1.3
1.3
—
—
—
0
0
460
4312
1.08
0.81
2.4
2.3
—
—
—
0
0
18
259
0.69
0.79
1.3
1.5
—
—
—
0
0
39
303
1.29
0.79
1.2
1.3
—
82.86
—
0
7
543
5129
1.08
0.79
1.6
1.6
—
—
—
0
0
32
243
1.32
0.77
1.3
1.1
—
—
—
0
0
79
668
1.19
0.77
1.3
1.6
—
—
—
0
0
0
28
0.00
0.76
0.0
8.6
—
—
—
0
0
118
1345
0.87
0.76
1.5
2.4
89.21
80.88
ml/min/173m2
2.54
57
534
63
522
1.21
0.76
1.4
1.4
311.04
317.71
ug/g
0.07
27
272
1046
10814
0.94
0.75
4.4
4.8
6.13
6.29
mmol/l
2.03
965
9933
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
109
1247
0.87
0.74
1.6
2.5
0.51
0.31
e6/l
0.25
103
1175
226
2472
0.91
0.73
2.7
2.4
9736.38
6982.23
u/l
0.35
97
954
8
132
0.60
0.73
1.8
2.3
—
—
—
0
0
18
254
0.71
0.73
1.8
1.5
—
—
—
0
0
173
1557
1.12
0.73
1.5
1.5
—
—
—
0
0
115
1308
0.87
0.72
1.4
1.7
0.19
0.26
mg/l
1.06
47
597
638
6689
0.94
0.72
2.4
2.7
0.00
0.04
estimate
0.85
153
1946
6
107
0.56
0.72
1.2
1.3
93.33
72.90
ug/l
—
6
107
175
1577
1.12
0.72
1.5
1.5
1.08
1.15
ratio
0.60
105
934
283
3057
0.92
0.71
1.6
1.6
1005.83
984.03
mu/l
0.15
244
2607
45
554
0.81
0.70
1.3
1.8
25.88
18.35
e6/l
0.12
25
411
175
1580
1.12
0.70
1.5
1.5
0.98
0.94
ratio
0.38
105
937
175
1580
1.12
0.70
1.5
1.5
1.25
1.21
ratio
0.21
105
943
180
1630
1.11
0.69
4.1
4.8
214.69
237.93
u/l
2.35
172
1561
5
93
0.54
0.67
1.4
1.2
—
—
—
0
0
10
154
0.65
0.64
1.2
2.1
31.00
32.16
pg
—
10
154
14
95
1.48
0.64
1.3
1.5
86.29
93.99
nmol/24h
0.12
14
95
67
570
1.18
0.64
1.8
2.1
1.28
1.36
g/l
0.36
58
518
47
565
0.83
0.61
1.3
1.9
133.26
7857.39
e6/l
0.60
31
441
0
20
0.00
0.60
0.0
9.0
—
10.83
—
0
20
88
770
1.15
0.60
1.2
1.4
218.63
228.41
u/ml
0.15
46
473
0
21
0.00
0.60
0.0
4.8
—
6.43
—
0
21
24
183
1.31
0.59
2.6
3.2
96.21
98.30
%
0.12
24
176
19
140
1.36
0.58
1.1
1.2
—
—
—
0
0
13
184
0.70
0.56
1.3
1.1
0.99
1.03
u/l
—
7
74
27
341
0.79
0.56
1.2
1.5
—
—
—
0
0
17
124
1.37
0.55
1.5
1.7
—
—
—
0
0
17
124
1.37
0.55
1.5
1.7
—
—
—
0
0
17
124
1.37
0.55
1.5
1.7
—
—
—
0
0
6
37
1.62
0.55
1.2
2.8
—
16641.67
—
0
6
97
861
1.13
0.55
1.2
1.2
—
—
—
0
0
36
439
0.82
0.55
1.8
2.0
2.25
2.21
ug/l
0.01
29
393
172
1579
1.10
0.54
1.3
1.3
222.26
229.19
miu/ml
0.10
89
787
17
125
1.36
0.53
2.6
1.7
1.34
3.46
nmol/l
0.65
12
94
17
125
1.36
0.53
1.1
1.2
—
—
—
0
0
393
4138
0.94
0.53
3.7
4.4
9.70
13.94
mg/mmol
0.32
230
2717
32
392
0.81
0.52
1.5
2.2
132.19
134.71
g/l
0.26
21
326
6
96
0.62
0.52
1.0
1.5
—
—
—
0
0
30
369
0.81
0.51
1.9
1.6
12670.22
12808.14
e6/l
0.01
23
259
179
1655
1.09
0.49
3.2
3.6
4.72
4.66
pmol/l
0.17
160
1506
528
5066
1.05
0.49
2.9
3.0
0.25
0.29
e6/l
0.29
353
3584
49
418
1.18
0.49
1.2
1.3
1.28
4.16
u/ml
2.61
18
153
7
111
0.63
0.48
1.3
1.3
—
—
—
0
0
44
517
0.85
0.48
1.4
1.7
—
—
—
0
0
180
1940
0.92
0.47
8.2
8.1
105.39
104.82
mmol/l
1.23
180
1940
34
409
0.83
0.47
1.6
1.5
—
—
—
0
0
26
209
1.25
0.46
1.4
1.7
—
—
—
0
0
8
120
0.67
0.45
1.3
1.5
—
—
—
0
0
35
415
0.84
0.43
2.2
5.3
—
1172.26
—
0
31
131
1204
1.09
0.43
1.8
1.7
—
—
—
0
0
6
91
0.66
0.42
1.0
1.5
—
—
—
0
0
8
57
1.40
0.42
1.4
1.1
—
—
—
0
0
10
70
1.43
0.41
1.1
1.1
—
—
—
0
0
45
388
1.16
0.41
1.1
1.1
112.16
114.98
%
0.23
38
357
15
195
0.77
0.41
1.1
1.1
1133.87
1403.49
miu/ml
0.69
15
195
13
96
1.36
0.41
1.6
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
5.3
—
—
—
0
0
90
815
1.11
0.40
3.1
3.5
93.71
95.32
%
0.35
83
792
8
60
1.33
0.40
1.4
1.1
—
—
—
0
0
8
60
1.33
0.40
1.5
1.1
—
—
—
0
0
43
371
1.16
0.40
2.7
3.2
20.66
24.80
mg/l
0.38
27
240
53
465
1.14
0.39
2.4
2.9
1.75
2.02
index
0.13
28
264
62
697
0.89
0.39
3.7
9.4
1.05
1.22
mg/l
3.00
56
661
7
101
0.69
0.39
1.0
1.5
—
—
—
0
0
8
61
1.31
0.39
1.4
1.1
—
—
—
0
0
8
61
1.31
0.39
1.8
2.0
110.09
102.54
ng/l
—
8
61
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
599
5809
1.04
0.37
2.9
3.2
30.65
95.32
e6/l
1.56
423
4302
11
146
0.75
0.36
6.4
6.0
7.45
8.36
%
0.32
11
146
11
146
0.75
0.36
3.2
3.0
53.45
44.70
%
0.82
11
146
20
245
0.81
0.36
2.1
1.2
58.33
32.27
u/l
0.22
20
216
1103
11226
0.97
0.34
2.9
3.4
0.00
4.78
estimate
2.06
185
2338
22
182
1.21
0.33
1.5
1.8
—
—
—
0
0
6
87
0.69
0.33
1.0
1.1
—
—
—
0
0
11
143
0.77
0.32
1.2
1.2
—
—
—
0
0
7
53
1.32
0.30
2.4
2.3
—
—
—
0
0
14
175
0.80
0.30
1.1
1.2
11.07
7.33
mm/h
0.82
14
175
179
1695
1.06
0.30
1.4
1.4
—
—
—
0
0
313
3009
1.05
0.30
2.7
3.2
876.45
597.36
ng/l
0.22
239
2394
7
54
1.30
0.30
4.0
6.1
—
—
—
0
0
77
706
1.09
0.30
2.7
2.7
5.11
6.23
umol/l
0.67
58
535
97
899
1.08
0.30
1.6
1.6
0.01
0.13
iu/ml
1.00
11
145
937
9545
0.97
0.30
2.7
2.7
—
—
estimate
—
0
0
7
56
1.25
0.29
1.1
1.1
—
—
—
0
0
18
217
0.83
0.29
1.3
1.3
0.49
0.69
ratio
3.82
13
118
168
1591
1.06
0.29
2.8
2.8
0.23
0.23
g/l
0.13
159
1504
28
241
1.16
0.29
1.2
1.3
—
—
—
0
0
584
5692
1.03
0.29
3.3
3.7
8.57
8.56
mmol/l
0.01
517
5094
43
481
0.89
0.28
1.3
1.7
—
—
—
0
0
97
1041
0.93
0.28
5.0
4.5
9.89
16.32
ug/l
0.36
71
770
22
258
0.85
0.27
1.1
1.7
—
—
—
0
0
9
120
0.75
0.27
1.1
1.3
—
77.00
%
—
0
13
9
121
0.74
0.27
2.2
2.7
53.22
51.00
umol/l
—
9
113
8
67
1.19
0.26
1.3
1.5
7.99
7.99
ug/l
—
8
67
69
747
0.92
0.25
1.9
2.1
3.04
3.81
iu/l
0.90
21
350
9
74
1.22
0.25
1.3
1.9
—
—
—
0
0
9
74
1.22
0.25
1.3
1.9
—
—
—
0
0
9
74
1.22
0.25
1.3
1.9
—
—
—
0
0
9
74
1.22
0.25
1.3
1.9
—
—
—
0
0
14
170
0.82
0.25
1.3
1.7
—
877064.21
—
0
14
375
3639
1.04
0.25
2.3
2.1
—
—
—
0
0
70
756
0.92
0.24
1.5
1.5
0.48
0.41
nmol/l
0.19
62
612
31
274
1.13
0.24
1.3
1.5
—
—
—
0
0
318
3283
0.96
0.24
1.6
1.6
410.14
25948047.02
pmol/l
2.61
284
2902
105
1115
0.94
0.24
8.1
6.3
24.21
24.00
mmol/l
0.37
105
1110
5
40
1.25
0.22
1.8
1.5
—
—
—
0
0
299
2898
1.04
0.22
3.1
3.1
993.60
543.80
ng/l
0.32
150
1578
11
135
0.81
0.22
1.1
1.3
73.82
70.85
umol/l
0.27
11
135
0
10
0.00
0.21
0.0
1.1
—
13.44
—
0
5
0
10
0.00
0.21
0.0
1.6
—
1.43
—
0
10
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
83
884
0.94
0.21
1.8
2.0
3.97
7.22
ug/l
2.50
75
794
189
1966
0.96
0.21
1.4
1.4
—
—
—
0
0
124
1179
1.05
0.21
1.8
2.3
31.04
32.88
u/ml
0.06
119
1139
41
450
0.91
0.21
1.2
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
3.7
—
—
—
0
0
14
117
1.20
0.20
1.9
3.7
0.64
0.77
index
0.38
14
117
19
219
0.87
0.20
1.1
1.1
—
—
—
0
0
6
49
1.23
0.20
1.0
1.0
4.57
5.94
u/ml
—
6
49
24
212
1.13
0.19
1.7
1.7
—
—
—
0
0
25
222
1.13
0.19
1.2
1.3
0.13
0.24
nmol/l
0.71
16
167
47
509
0.92
0.19
1.8
2.4
235.72
278.51
ug/l
0.15
42
474
20
228
0.88
0.19
1.4
1.8
—
—
—
0
0
1100
11122
0.98
0.19
2.9
3.4
0.00
0.00
estimate
0.80
187
2351
6
53
1.13
0.18
1.3
2.2
—
—
—
0
0
6
53
1.13
0.18
1.3
2.2
—
—
—
0
0
6
53
1.13
0.18
1.3
2.2
—
—
—
0
0
120
1146
1.05
0.18
3.0
4.9
64.21
72.74
ng/l
1.15
113
1051
38
413
0.92
0.17
4.9
4.0
21.20
585.48
u/ml
1.00
33
356
36
392
0.92
0.17
1.6
1.4
—
—
—
0
0
39
423
0.92
0.17
1.3
2.9
1.04
0.86
nmol/l
0.55
34
367
487
4783
1.02
0.16
2.0
2.1
164.14
208.68
u/l
0.74
463
4589
33
360
0.92
0.16
1.9
3.6
5.48
6.77
pmol/l
1.64
33
360
748
7381
1.02
0.16
2.7
3.3
27.84
30.22
u/l
1.54
713
7051
31
283
1.10
0.16
1.3
1.1
—
—
—
0
0
108
1127
0.96
0.15
1.5
1.5
—
—
—
0
0
6
78
0.77
0.15
1.0
1.3
118.83
93.38
nmol/l
—
6
57
20
223
0.90
0.14
1.2
1.7
—
—
—
0
0
248
2421
1.03
0.14
2.4
2.7
29.22
29.30
s
0.09
241
2354
941
9325
1.01
0.12
5.1
5.9
10.49
10.56
umol/l
0.06
891
8843
41
386
1.06
0.11
1.3
2.6
—
—
—
0
0
393
3871
1.02
0.11
2.2
2.7
6.90
7.82
e6/l
0.48
347
3518
74
771
0.96
0.11
2.6
3.0
97.44
103.89
ng/l
0.11
61
664
165
1610
1.03
0.10
3.5
4.7
—
—
—
0
0
26
280
0.93
0.10
1.4
2.0
—
—
—
0
0
22
238
0.92
0.09
1.4
1.1
—
—
—
0
0
39
369
1.06
0.09
1.8
2.9
—
—
—
0
0
40
421
0.95
0.09
1.2
1.1
220.72
1206.31
iu/ml
0.44
11
116
19
206
0.92
0.08
1.6
1.2
—
—
—
0
0
6
56
1.07
0.08
1.0
1.3
—
—
—
0
0
6
56
1.07
0.08
1.0
1.3
—
—
—
0
0
35
369
0.95
0.08
1.4
1.5
6.23
6.69
mmol/l
0.61
35
339
212
2156
0.98
0.08
4.1
7.5
1.08
1.08
mmol/l
0.20
190
2031
7
67
1.04
0.08
1.9
2.4
77.43
73.74
ug/l
—
7
67
19
205
0.93
0.08
1.6
1.2
—
—
—
0
0
65
629
1.03
0.07
1.2
1.6
176.80
144.39
au/ml
1.58
20
189
581
5764
1.01
0.07
2.2
2.7
15.32
45.07
ng/l
1.27
232
2696
136
1334
1.02
0.06
1.1
1.1
0.63
0.63
ratio
0.03
17
117
8
94
0.85
0.06
1.9
2.1
16.39
15.86
umol/l
—
8
94
1121
11259
0.99
0.06
3.0
3.4
0.00
0.01
estimate
1.57
185
2253
16
172
0.93
0.06
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
316
1.04
0.05
3.0
5.8
0.36
0.36
iu/ml
0.01
18
151
25
238
1.05
0.05
1.3
1.6
—
—
—
0
0
29
302
0.96
0.04
1.3
1.8
—
—
—
0
0
38
368
1.03
0.04
1.2
1.2
—
—
—
0
0
35
361
0.97
0.03
1.2
1.4
—
—
—
0
0
171
1725
0.99
0.03
1.5
1.8
—
—
—
0
0
42
410
1.02
0.02
1.2
1.2
—
—
—
0
0
115
1139
1.01
0.02
1.4
1.5
—
—
—
0
0
177
1781
0.99
0.01
1.5
1.7
—
—
—
0
0
12
127
0.94
0.01
1.3
1.6
—
—
—
0
0
13
124
1.05
0.00
1.3
1.1
—
—
—
0
0
14
135
1.04
0.00
1.4
1.8
—
—
—
0
0
12
121
0.99
0.00
1.1
1.1
93.57
92.41
%
—
7
98
12
121
0.99
0.00
1.1
7.3
—
252.16
—
0
32
12
118
1.02
0.00
1.3
1.2
—
—
—
0
0
24
238
1.01
0.00
1.2
1.6
—
—
—
0
0
7
73
0.96
0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
9
93
0.97
-0.00
1.1
2.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
1.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
9.8
—
—
—
0
0
11
110
1.00
-0.00
1.5
1.4
170.09
159.65
mmol/24h
0.21
11
110
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
5.13
—
0
8
34
340
1.00
-0.00
2.4
3.3
1.82
2.14
mmol/l
0.34
15
191
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
59
0.85
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.4
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
5.17
—
0
6
87
870
1.00
-0.00
1.5
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
93
0.97
-0.00
1.1
2.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.6
—
0.32
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
7
71
0.99
-0.00
1.4
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_DESEN_ALLERGE – Desensitization to allergens
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).